Stocks in play: Sernova Corp.

Announced the U.S. Food and Drug Administration (FDA) has granted both Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) for the company’s Hemophilia A program. Sernova Corp. shares T.SVA are trading up $0.02 at $2.75.

Read:

• Investing in Hope: Biotech Innovations Targeting Increased Breast Cancer Rates in 2023

• Tech Industry Titans Clash Over Artificial Intelligence Superiority Ahead of $1.3 Trillion Market

• The Stakes are High in the Ongoing AI Arms Race Among Major Tech Companies

• Why Pancreatic Cancer is No Longer a Death Sentence: Emerging Therapies to Watch

• Mining Industry's Strategic Shifts: Gold Reshuffling in Response to Inflation and Sanctions